Category: Immunotherapy

  • FDA OKs New Keytruda Shot for Cancer

    The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.

  • The Medicine Is a Miracle, but Only if You Can Afford It

    The New York Times – Business:

    A wave of new treatments have cured devastating diseases. When the costs are too much, even for the insured, patients hunt for other ways to pay.